biontech se news - Search News

BioNTech, ADR

BioNTech SE ADR falls Wednesday, underperforms market

The BioNTech SE ADR BNTX slipped 7.29% to $115.62 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to 5,618.26 and Dow Jones Industrial Average DJIA falling 0.

Fintel on MSN · 2d

Jefferies Upgrades BioNTech SE - Depositary Receipt () (BNTX)

Fintel reports that on September 17, 2024, Jefferies upgraded their outlook for BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) from Hold to Buy. Analyst Price Forecast Suggests 8.06% Downside As of August 25,

Business Insider · 1d

UBS Keeps Their Hold Rating on BioNTech SE (BNTX)

UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The

MarketWatch · 2d

BioNTech SE ADR rises Tuesday, outperforms market

The BioNTech SE ADR BNTX rallied 1.00% to $124.71 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.03% to 5,634.58 and the Dow Jones Industrial Average DJIA falling 0.04% to 41,606.18.

Fintel on MSN · 3d

JP Morgan Upgrades BioNTech SE - Depositary Receipt () (BNTX)

Fintel reports that on September 16, 2024, JP Morgan upgraded their outlook for BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) from Underweight to Neutral. Analyst Price Forecast Suggests 8.01% Downside As of August 25,

BioNTech SE: A Strong Buy on BNT327’s Promising Cancer Treatment Prospects and Financial Fortitude

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...

Zacks.com on MSN6d

BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?

BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Here's Why Everyone's Talking About Summit Therapeutics

Summit Therapeutics acquired rights to ivonescimab outside of China and Australia. With Keytruda sales up around $25 billion ...

2don MSN

BioNTech raised to buy at Jefferies on new cancer drug

BioNTech (BNTX) stock traded higher on Tuesday after Jefferies upgraded the COVID-19 vaccine maker to Buy, citing the ...

Morningstar2d

BioNTech SE ADR BNTX

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nasdaq6d

BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?

BioNTech SE Sponsored ADR (BNTX) shares soared 5.8% in the last trading session to close at $105. The move was backed by solid volume with far more shares changing hands than in a normal session.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results